Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Evaluation of AP-002 in Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AP-002 in patients with solid tumors is ongoing, with unknown current status.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy [Phase 1]
First-in-human Phase 1 trial assessing safety, tolerability, and PK/PD of VX-984 in combination with chemotherapy in patients with advanced …
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: A Study of LY2510924 and Durvalumab in Participants With Solid Tumors [Phase 1]
Phase 1 trial investigating LY2510924 in combination with durvalumab in participants with solid tumors; the study status is terminated with …
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study [Phase 3]
Extension study of onartuzumab in participants with solid tumors previously treated in a sponsor study; completed Phase 3 trial.
-
CLINICAL_TRIALS research · 2019-07-23Clinical Trial Update: HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors [Phase 1]
Phase 1 trial investigating hydroxychloroquine (HCQ) effects on PAR-4 levels in patients with resectable solid tumors; study completed with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: AZD8186 and Paclitaxel in Advanced Gastric Cancer [Phase 1, Phase 2]
A clinical trial update for AZD8186 combined with paclitaxel in advanced gastric cancer undergoing Phase 1 and Phase 2 exploration.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: BGJ398 for Patients With Tumors With FGFR Genetic Alterations [Phase 2]
Phase 2 trial update of BGJ398 (infigratinib) for tumors with FGFR genetic alterations; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread [Phase 1]
Phase 1 trial update for LY2334737 in advanced/metastatic cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody [Phase 2, Phase 3]
Clinical trial exploring anlotinib plus PD-1 antibody for second-line and above treatment of advanced solid tumors in Phase 2/3.
-
CLINICAL_TRIALS research · 2019-05-07Clinical Trial Update: Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors [Phase 1, Phase 2]
Clinical trial exploring ROBO1-specific CAR-NK cell therapy for solid tumors in early phase studies.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating vinorelbine in patients with advanced solid tumors that did not respond to treatment and liver dy…
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial examining how fluconazole and itraconazole affect MLN4924 pharmacokinetics, safety, and tolerability in participants with adva…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: A Study of Talazoparib in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of talazoparib in patients with advanced solid tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer [Phase 1]
A Phase 1 trial update for TH-302 in subjects with solid tumors and pancreatic cancer has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors [Phase 1, Phase 2]
A clinical trial updating combination chemotherapy with pazopanib in children and adolescents with relapsed or refractory solid tumors (Phas…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Pegteograstim in Children With Solid Tumors [Phase 2]
Phase 2 clinical trial update for Pegteograstim in pediatric patients with solid tumors undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial update for mesoCAR-T cells expressing PD-1 antibody targeting mesothelin in advanced solid tumors; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement [Phase 2]
Phase 2 study evaluating 5 μg/kg Tbo-filgrastim in infants, children, and adolescents with solid tumors without bone marrow involvement has …
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating PT-112 in combination with docetaxel in patients with advanced solid tumors and non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a safety and efficacy study of Ulocuplumab with Nivolumab in solid tumors; trial terminated with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Indocyanine Green for Solid Tumors [Phase 1]
This clinical trial update notes a completed Phase 1 study of indocyanine green for solid tumors.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas [Phase 2]
This document provides an update on a Phase 2 trial evaluating two dosing schedules of perifosine in patients with solid tumors or lymphomas…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Cabozantinib in Advanced Solid Malignancies [Phase 2]
Phase 2 clinical trial of cabozantinib in advanced solid malignancies completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients [Phase 1, Phase 2]
A clinical trial update evaluating WX-0593 in advanced solid tumors and non-small cell lung cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+ [Phase 1]
A Phase 1 trial evaluating a quadruple regimen (neratinib, trastuzumab, pertuzumab, paclitaxel) in patients with advanced HER2-positive soli…